Chromogranin A levels and mortality in patients with severe sepsis

Chih-Hsin Hsu, Luis F. Reyes, Carlos J. Orihuela, Ricardo Buitrago, Antonio Anzueto, Nilam J. Soni, Stephanie Levine, Jay Peters, Cecilia A. Hinojosa, Stefano Aliberti, Oriol Sibila, Alejandro Rodriguez, James D. Chalmers, Ignacio Martin-Loeches, Jose Bordon, Jose Blanquer, Francisco Sanz, Pedro J. Marcos, Jordi Rello, Jordi Solé-ViolánMarcos I. Restrepo (Lead / Corresponding author)

    Research output: Contribution to journalArticlepeer-review

    8 Citations (Scopus)


    Context: Chromogranin A (CgA) is a novel biomarker with potential to assess mortality risk of patients with severe sepsis.Objective: Assess association of CgA levels and mortality risk of severely septic patients.Methods: Serum CgA levels were measured in 50 hospitalized, severely septic patients with organ failure <48 h.Results: Higher CgA levels trended toward higher ICU and hospital mortality. Patients without cardiovascular disease who died in the ICU had higher median (IQR) CgA levels 602.3 (343.3, 1134.3) ng/ml versus 205.5 (130.7, 325.9) ng/ml, p = 0.01.Conclusions: High CgA levels predict ICU mortality in severely septic patients without prior cardiovascular disease.

    Original languageEnglish
    Pages (from-to)171-176
    Number of pages6
    Issue number3
    Publication statusPublished - 2015


    • Biological marker
    • Cardiovascular diseases
    • Chromogranin A
    • Mortality
    • Sepsis

    ASJC Scopus subject areas

    • Biochemistry
    • Clinical Biochemistry
    • Health, Toxicology and Mutagenesis


    Dive into the research topics of 'Chromogranin A levels and mortality in patients with severe sepsis'. Together they form a unique fingerprint.

    Cite this